Asahi Kasei

About This Fund

Asahi Kasei is an institutional investor (Conventional VCs) founded in 2008 and headquartered in Menlo Park, California, United States (and 3 other locations). Investing in materials, homes, and healthcare for a better future. The company focuses on venture capital investments across diverse sectors including energy, materials, IoT, industrial AI, digital health, medical devices, pharma services, therapeutics, construction, and real estate. It seeks innovative companies developing solutions for airborne infection control, AI-driven treatment adherence, rare pediatric neurological diseases, lithium-ion battery technology, digital olfaction, neuromodulation, industrial wastewater treatment, lysosomal storage disorders, additive manufacturing, digital product passports, drug discovery, cell and gene therapy, industrial IoT, polymeric pharmaceuticals, intracellular delivery, rare genetic disorders, brain tumor treatment, fresh produce shelf life extension, histopathology data collaboration, electromagnetic field measurement, implantable devices for CHF, ion-exchange membranes, lentiviral vector solutions, personalized physical therapy, lymphatic and venous care, mitochondrial therapeutics, cell analyzers, lithium processing, battery energy storage, cellular agriculture, plastic-free materials, wearable therapeutics, real estate robotics, clean hydrogen production, autonomous welding, peptide therapeutics, prefab homes, pulmonary disease therapies, kidney disease solutions, plastic recycling, transportation solutions, bioelectronic medicine, manufacturing data platforms, offsite framing, AI-driven home remodeling, blockchain-based asset tokenization, home care subscriptions, digital therapeutics, synthetic DNA development, construction materials marketplace, acoustic detection in batteries, water treatment, ultrasound sensors, disinfection technology, biosensor technology, alternative asset platform, connected worker platform, and IIoT localization. Practice areas include Investment Industry. The firm operates as Venture Capital Funds. Key investment sectors include Artificial Intelligence, Healthcare / HealthTech, Biotech / Biopharma, CleanTech / ClimateTech / Energy, and 7 more.

Investment Focus